When the skin is irradiated with UVB light, various cytokines are released, act on normal human melanocytes (NHMC), and induce them to synthesize melanin pigment, to proliferate and to differentiate, which leads to increased pigmentation.
10 nM 20 h later, the cells were labeled for 4 h with 1.0 mCi/ml [ 3 H]thymidine. After 3 washes with phosphatebuffered saline (PBS), the cells were trypsinized and harvested on glass fiber filters, washed 3 more times with distilled water, twice with ice-cold ethanol, and then dried. The radioactivity on each filter was directly measured using MA-TRIX 96 (Packard Bioscience Co.).
Measurement of [
125 I]ET-1 Binding These techniques were performed according to the method of Yada et al. 1) NHMC were seeded in 24-well culture trays at a density of 4ϫ10 4 ) and bound [ 125 I]ET-1 was determined after solubilization of the cell layer with 1 N NaOH. Cell-associated radioactivity was measured 1) and specific binding was calculated as total binding minus nonspecific binding in the presence of 1 mM unlabeled ET-1.
Measurement of Inositol 1,4,5-Trisphosphate (IP 3 )
These techniques were performed according to the method of Yada et al. 1) NHMC were seeded in 24-well culture trays at a density of 6ϫ10 4 cells/cm 2 and were cultured for 48 h. The media were aspirated and modified SFM without supplements, but containing 10 mM LiCl, was added and incubated for 10 min at 37°C before stimulation. The ligand stimulation was terminated at designated times by adding 10% perchloric acid and the samples were kept on ice for 15 min. After neutralization with ice-cold 1.5 M KOH for 60 min on ice, the samples were centrifuged at 2000ϫg for 10 min to remove KClO 4 precipitate. The supernatants were subjected to IP 3 assay using an IP 3 assay kit (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom). The content of IP 3 in each sample was quantitatively determined from a calibration curve established using the binding protein specific for IP 3 3 . Extraction of Cellular Proteins Cells were incubated with ET-1 in 6-well culture trays, then solubilized in 500 ml of ice-cold RIPA (radioimmunoprecipitation) buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.25% Na deoxycholate, 1 mM EDTA, 50 mM NaF, 1 mM sodium orthovanadate, 50 mM phenylmethylsulfonyl fluoride, and 1 mg/ml aprotinin. The mixtures were sonicated briefly and were then centrifuged at 14000ϫg for 60 min at 4°C. Protein concentrations in the supernatants were determined by the BCA assay kit (Pierce Chemical Co., Tokyo, Japan).
Western Blotting To measure mitogen activated protein kinase (MAPK) activity in NHMC, Western blotting was performed according to Imokawa et al. 9) Lysates (20 mg/lane) were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to Immobilon-P PVDF membranes (Millipore, Eschborn, Germany). Membranes were blocked with 3% bovine serum albumin in Tris-buffered saline containing Tween 20 (TBS-T) buffer (20 mM Tris-HCl, pH 7.2, 0.14 M NaCl, 0.1% Tween 20) for 3 h at room temperature, and were then probed with a-phosphospecific ERK1/2 or aERK1/2 antibodies (New England Biolabs, Inc., MA, U.S.A.) in TBS-T buffer. After washing, blots were incubated with horseradish peroxidase-conjugated secondary antibody (Amersham) for 1 h, and signals were visualized using enhanced chemiluminescence (ECL) detection reagents (Amersham).
Immuno-Affinity Chromatography Immuno-affinity columns were prepared by covalently linking the anti-peptide IgG to protein A-Sepharose columns using IgG Orientation Kits (Pierce), according to the manufacturer's instructions and as detailed elsewhere. 10, 11) B16 F10 melanoma cells growing subcutaneously in mice were excised, homogenized gently, and lysed in 155 mM NH 4 Cl, 10 mM KHCO 3 , and 0.1 mM EDTA. The cells were washed in ice-cold PBS(Ϫ) and then solubilized in Nonidet P-40/SDS buffer overnight at 4°C. Identical aliquots (ca. 50 mg protein) of the soluble supernatant fraction were bound to each immuno-affinity column and nonabsorbed proteins were washed through with 30-40 ml of Nonidet P-40/SDS buffer. Specifically absorbed proteins were then removed from the column with 10 ml of the elution buffer supplied with the columns. Both the bound and unbound fractions were dialyzed versus 0.01% Nonidet P-40, 0.01 M Tris buffer, pH 7.2, with phenylmethylsulfonyl fluoride (PMSF) and aprotinin, overnight at 4°C. These samples were then used for Western blotting for purity analysis, as detailed above, or for assay of melanogenic activities, as detailed below.
Melanogenic Assays (i) Measurement of Dopa Oxidase Activity: These techniques were performed according to Kobayashi et al. 12) NHMC were solubilized in extraction buffer [0.1 M Tris-HCl (pH 7.2), 0.01% Nonidet P-40, 0.01% SDS, 100 mM PMSF, and 1 mg/ml aprotinin], and the supernatant after centrifugation at 10000ϫg was used as the crude tyrosinase extract in order to measure enzyme activity. Dopa oxidase activity was measured by the 3-methyl-2-benzothiazolinone hydrazone (MBTH) assay, as reported previously.
13) The reaction mixture contained assay buffer (50 mM sodium phosphate, pH 7.1, and 2% dimethylformamide), 1 mM L-dopa and 6 mM MBTH, at a final pH of 6.9. The reaction mixture, without enzyme, was incubated at 37°C for 10 min. Dopa oxidase enzyme preparation (the crude tyrosinase) was then added and mixed. Conversion of the substrate dopa to dopaquinone by the crude tyrosinase extract was measured by color reaction with MBTH and the absorbance at 505 nm was measured. It was monitored spectrophotometrically, routinely over a period of 5 min. Dopa and MBTH were obtained from Sigma Chemical Co. (Saint Louis, Missouri, U.S.A.). (ii) Measurement of dopachrome tautomerase activity: Measurement of dopachrome tautomerase activity was measured by high performance liquid chromatography (HPLC) as the disappearance of dopachrome substrate and the production of 5,6-dihydroxyindole-2-carboxylic acid (DHICA).
11,14,15) Dopa-chrome and purified tyrisinase-related protein 2 (TRP2) 14) were reacted at 37°C for 1 h, and the production of DHICA from the substrate was quantified by HPLC. A C18 reversed phase column was used, and the sample was applied at a flow rate of 0.5 ml/min using a buffer of 0.15 M sodium borate buffer (pH 2.5) and 25% methanol. Elution of peaks was monitored by A 280 . Dopachrome substrate was prepared using the silver oxide method originally described by Körner and Pawelek. 16) ELISA For ELISA assay to measure ET-1, NHKC were seeded in 48-well culture dishes at a density of 2ϫ10 4 cells/cm 2 and were cultured for 48 h. The medium was then aspirated, exchanged for fresh medium as described above, and the cells were cultured for another 48 h. The conditioned medium was collected and quantified in 100 ml/well for ET-1 by ELISA. The ET-1 ELISA kit is a solid phase enzyme immunoassay using the multiple antibody sandwich principle. A human purified polyclonal antibody specific for human ET-1 was attached to 96-well microtiter plates. ET-1 in the conditioned media and standards was captured by the solid phase antibody. Horseradish peroxidase-labeled rabbit antihuman ET-1 IgG was then added, which bound to multiple epitopes on ET-1 attached to the solid phase. Levels of immunoreactive ET-1 were measured by absorbance at 450 nm using a Model 3550 ELISA plate reader (Bio-Rad Laboratories, Hercules, CA, U.S.A.). The amount of ET-1 in the culture media was determined by comparing their absorbance to that produced by standards.
Statistics Statistical analysis was performed by one-way analysis of variance followed by Dunnett's test and a value of pϽ0.05 was considered significant.
RESULTS
Effect on Mobilization of Intracellular Calcium of NHMC Fura-2/AM fluorescence analysis ( Fig. 1) revealed that adding ET-1 to NHMC induced a marked accumulation of intracellular calcium.
1) 5 nM ET-1 caused NHMC to markedly increase intracellular calcium levels (Fig. 1A) , but the pretreatment with the extract of A. officinalis completely abolished the intracellular calcium increase of NHMC induced by 5 nM of ET-1 (Fig. 1B) .
Effect on Proliferation of NHMC As shown in Fig. 2 , the ET-1-induced increase in thymidine uptake 1) was inhibited by treatment with the extract of A. officinalis in a dosedependent manner, and approximately 50% of the thymidine uptake was inhibited when 0.5% (v/v) of this extract was added. No change in thymidine uptake was noted in the absence of the extract.
In the absence of ET-1, the number of NHMC did not change after addition of 0.05-0.5% of the extract, confirming that it does not affect proliferation of the cells. When ET-1 was added, cell proliferation of NHMC increased, but the increase in the number of the cells was inhibited in a dosedependent manner after addition of 0.05-0.5% of the extract (Fig. 3, Table 1 ). 
Effect on Signal Transduction in NHMC
The binding of ET-1 to its receptor was then examined. The ET-1 receptor B type inhibitor BQ788 17) strongly inhibited the binding of ET-1 to the receptor (Fig. 4A ), but the extract of A. officinalis did not inhibited the binding of ET-1 (Fig. 4B) .
Intracellular IP 3 production transiently increased and reached a peak 30 s after stimulation with ET-1 (Fig. 5) . The extract of A. officinalis did not inhibit the IP 3 production.
Next, the effect of the extract on the activation of MAPK was examined. Transient phosphorylation of MAPK was observed 2-6 min after stimulation with ET-1 (data not shown). This ET-1-induced activation of MAPK could be inhibited by the extract of A. officinalis (when examined 5 min after stimulation with ET-1), and the inhibitory effect was observed at concentrations of 0.1% and 1% (Fig. 6) .
Effect on Tyrosinase and Tyrosinase-Related Enzymes The effect of the A. officinalis extract on tyrosinase was investigated using the dopa oxidase assay.
12) The tyrosinase inhibitor arbutin (Sigma) weakly inhibited the enzyme activity while kojic acid (Tokyo Kasei Industry, Tokyo, Japan) strongly inhibited it. In contrast, the extract of A. officinalis did not inhibit tyrosinase activity (Fig. 7) .
The tyrosinase-related enzyme TRP2 has dopachrome tautomerase activity 11, 18) which results in the conversion of dopachrome to DHICA. The effect of the extract on TRP2 was examined, and the amount of DHICA production did not change after addition of the extract at a concentration of 1% (Fig. 8) .
Effect on ET-1 Production in NHKC ET-1 production in NHKC was inhibited after addition of the extract at concentrations of 0.01-0.5%, in a dose-dependent manner (Fig.  9 ).
DISCUSSION
In this study, an extract of A. officinalis was found to inhibit intracellular calcium mobilization in NHMC activated by ET-1, and to strongly inhibit ET-1-induced proliferation of melanocytes. These findings suggest that this extract significantly diminishes the physiological effect of ET-1 on NHMC following UVB irradiation. ET-1 is known to activate various intracellular signal transduction pathways in melanocytes. 19) ET-1 binds to the ET B R on the melanocyte cell surface and activates phospholipase C via a G protein; IP 3 and diacylglycerol (DAG) are then produced by inositol phospholipid metabolism. As a result, IP 3 releases calcium from the endoplasmic reticulum to increase the intracellular calcium concentration, which activates Raf-1 located upstream of MAPK. DAG has been reported to activate MAPK via protein kinase C. The action of ET-1 is transmitted to stimulate cell proliferation mainly via MAPK. 9, 20) The present study showed that the extract of A. officinalis did not affect the intracellular signal transduction pathway located upstream of calcium mobilization, i.e., the binding of ET-1 to the ET B R on NHMC or the production of IP 3 . In contrast, the ET-1-induced activation of MAPK was inhibited by the extract. Therefore, the extract of A. officinalis is thought to act on both processes of calcium mobilization and of MAPK activation, the sum of which result in the inhibition of ET-1-induced activation of NHMC. When we examined the possibility that this extract directly inhibited tyrosinase and/or tyrosinase-related enzyme activities, the primary targets in whitening cosmetics, it did not inhibit the activity of either enzyme.
In addition to the inhibitory effects of the extract of A. officinalis on NHMC, we found that it also inhibited ET-1 secretion from NHKC. Therefore, this extract has dual potential whitening effects by down-regulating keratinocyte and melanocyte function. Since Big ET-1, an inactive precursor of ET-1, is enzymatically cleaved by endothelin-converting enzyme (ECE) to form mature ET-1, it is possible that this botanical extract affects the synthesis or processing of Big ET-1 and thereby reduces ET-1 production by NHKC. The precise mechanism by which this extract regulates ET-1 secretion from NHKC remains to be elucidated.
ET-1 is likely to contribute to UVB-induced pigmentation. Therefore, it is suggested that inhibition of the ET-1-induced activation of NHMC results in the inhibition of pigmentation, and that the extract of A. officinalis is a potent ingredient for a whitening agent. Current whitening agents have been developed mainly based on studies of tyrosinase 21) in melanocytes, and inhibition of tyrosinase activity has been a primary strategy in the search for whitening agents. However, it may be very difficult for such agents to reach the melanosomes 22) in which tyrosinase acts at a sufficient dose to be effective. On the other hand, since ET-1 has been reported to promote transcription of tyrosinase, 3) this extract might inhibit tyrosinase function by inhibiting its activation The extract at concentrations of 0.01-0.5% was added to NHKC and the cells were cultured for 2 d. The amount of ET-1 secreted into the culture medium was analyzed by ELISA, as described in Materials and Methods. The values reported are meansϮS.E.M. derived from three wells. * * pϽ0.01 from control.
by ET-1 in addition to its inhibitory effect on melanocyte proliferation, even though the extract does not directly inhibit tyrosinase activity. Therefore, this extract may actually be more effective in reducing tyrosinase function than are the current whitening agents that target tyrosinase. Furthermore, the inhibitory effect of this botanical extract may be enhanced synergistically by combination with other cosmetics.
It has been reported that expression of ET-1 23) and its receptors is increased 24) in seborrhoeic keratosis and in senile pigmented freckles. Involvement of a mechanism similar to the UVB-induced activation of melanocytes has been suggested for these pigmentation disorders, and thus treatment with the extract of A. officinalis might also be effective in whitening other than hyperpigmentary conditions associated with ET-1 function.
In conclusion, these findings suggest that the mechanisms involved in the inhibitory effects of the extract of A. officinalis include the inhibition of ET-1-induced activation of the intracellular signal transduction pathway (which inhibits melanocyte proliferation) and also the production of ET-1 in keratinocytes (which inhibits melanocyte differentiation). Therefore, the extract of A. officinalis has multiple effective actions and it may be a useful ingredient that inhibits the pigmentation that would normally be stimulated by ET-1 following UVB irradiation.
